Retour
37
Fourchette du Jour
53,36 €
54,37 €
Fourchette 52 Semaines
50,76 €
73,18 €
Volume
1 648 594
Moyenne 50J / 200J
58,63 €
/
56,59 €
Clôture Précédente
54,78 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 29,8 | 0,3 |
| P/B | 1,7 | 2,9 |
| ROE % | 5,9 | 3,7 |
| Net Margin % | 10,8 | 3,8 |
| Rev Growth 5Y % | 14,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
86,60 €
+60.1%
Low: 60,00 €
High: 105,00 €
P/E Prévisionnel
12,7
BPA Prévisionnel
4,32 €
Croissance BPA (est.)
+0,0%
CA Est.
3,6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,40 €
7,98 € – 8,82 €
|
5,1 B | 6 |
| FY2029 |
7,57 €
7,19 € – 7,96 €
|
4,8 B | 6 |
| FY2028 |
6,76 €
4,90 € – 9,01 €
|
4,4 B | 8 |
Points Clés
Revenue grew 14,93% annually over 5 years — strong growth
Earnings declined -18,26% over the past year
Debt/Equity of 0,11 — conservative balance sheet
Generating 724,96M in free cash flow
Cash machine — converts 207,78% of earnings into free cash flow
Capital efficient — spends only 3,20% of revenue on capex
Croissance
Revenue Growth (5Y)
14,93%
Revenue (1Y)12,87%
Earnings (1Y)-18,26%
FCF Growth (3Y)240,39%
Qualité
Return on Equity
5,94%
ROIC5,95%
Net Margin10,83%
Op. Margin16,56%
Sécurité
Debt / Equity
0,11
Current Ratio5,21
Interest Coverage48,95
Valorisation
P/E Ratio
29,82
P/B Ratio1,71
EV/EBITDA18,25
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,87% | Revenue Growth (3Y) | 15,39% |
| Earnings Growth (1Y) | -18,26% | Earnings Growth (3Y) | 44,26% |
| Revenue Growth (5Y) | 14,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,22B | Net Income (TTM) | 348,90M |
| ROE | 5,94% | ROA | 4,59% |
| Gross Margin | 77,13% | Operating Margin | 16,56% |
| Net Margin | 10,83% | Free Cash Flow (TTM) | 724,96M |
| ROIC | 5,95% | FCF Growth (3Y) | 240,39% |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 5,21 |
| Interest Coverage | 48,95 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 29,82 | P/B Ratio | 1,71 |
| P/S Ratio | 3,23 | PEG Ratio | -1,71 |
| EV/EBITDA | 18,25 | Dividend Yield | 0,00% |
| Market Cap | 10,40B | Enterprise Value | 9,73B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,22B | 2,85B | 2,42B | 2,10B | 1,85B |
| Net Income | 348,90M | 426,86M | 167,65M | 141,56M | -64,08M |
| EPS (Diluted) | 1,80 | 2,21 | 0,88 | 0,75 | -0,35 |
| Gross Profit | 2,48B | 2,27B | 1,89B | 1,59B | 1,38B |
| Operating Income | 533,48M | 484,21M | 185,77M | 160,97M | -82,34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7,59B | 6,99B | 6,84B | 6,38B | 6,00B |
| Total Liabilities | 1,51B | 1,33B | 1,89B | 1,77B | 1,74B |
| Shareholders' Equity | 6,09B | 5,66B | 4,95B | 4,60B | 4,27B |
| Total Debt | 642,87M | 649,47M | 1,10B | 1,09B | 1,09B |
| Cash & Equivalents | 1,31B | 942,84M | 755,13M | 724,53M | 587,28M |
| Current Assets | 3,95B | 3,23B | 2,96B | 2,75B | 2,27B |
| Current Liabilities | 759,03M | 606,99M | 1,18B | 588,88M | 546,50M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#697 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026